IRONWOOD PHARMACEUTICALS INC (IRWD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 200M 400M 600M Q3 '16: 239.8M Q4 '16: 274M Q1 '17: 260.1M Q2 '17: 270.8M Q3 '17: 291.5M Q4 '17: 298.3M Q1 '18: 315.3M Q2 '18: 331.3M Q3 '18: 310.2M Q4 '18: 346.6M Q1 '19: 346.2M Q2 '19: 367.3M Q3 '19: 432.8M Q4 '19: 428.4M Q1 '20: 439.6M Q2 '20: 426.8M Q3 '20: 399.1M Q4 '20: 389.5M Q1 '21: 398.4M Q2 '21: 413M Q3 '21: 413.3M Q4 '21: 413.8M Q1 '22: 422.4M Q2 '22: 415.6M Q3 '22: 420.5M Q4 '22: 410.6M Q1 '23: 417.1M Q2 '23: 427.3M Q3 '23: 432.4M Q4 '23: 442.7M Q1 '24: 413.6M Q2 '24: 400.6M Q3 '24: 378.4M Q4 '24: 351.4M Q1 '25: 317.7M Q2 '25: 308.5M Q3 '25: 339M Q4 '25: 296.2M Q1 '26: 361.5M Q2 '26: 389.3M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 150M 300M 450M Q4 '17: 279.2M Q1 '18: 294.1M Q2 '18: 309.6M Q3 '18: 289.9M Q4 '18: 313.9M Q1 '19: 315M Q2 '19: 328.9M Q3 '19: 398.5M Q4 '19: 404.5M Q1 '20: 414.6M Q2 '20: 413.1M Q3 '20: 385.9M Q4 '20: 386.4M Q4 '17 Q2 '18 Q4 '18 Q2 '19 Q4 '19 Q2 '20 Q4 '20

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-1.1B -700M -350M 0 350M 700M 1.1B Q3 '16: -51.4M Q4 '16: -51.9M Q1 '17: -89.6M Q2 '17: -115.3M Q3 '17: -106.5M Q4 '17: -15.4M Q1 '18: -11.5M Q2 '18: 14.8M Q3 '18: -112.3M Q4 '18: -150.7M Q1 '19: -131.7M Q2 '19: -95.5M Q3 '19: 117M Q4 '19: 120.1M Q1 '20: 150.3M Q2 '20: 161.4M Q3 '20: 141.1M Q4 '20: 142.9M Q1 '21: 175.1M Q2 '21: 207.5M Q3 '21: 227.1M Q4 '21: 232.3M Q1 '22: 244.7M Q2 '22: 235.3M Q3 '22: 238.6M Q4 '22: 250.3M Q1 '23: 252.6M Q2 '23: -886.2M Q3 '23: -914.7M Q4 '23: -945.4M Q1 '24: -994.5M Q2 '24: 113.6M Q3 '24: 99.2M Q4 '24: 93.1M Q1 '25: 53M Q2 '25: 73.3M Q3 '25: 123.2M Q4 '25: 98.5M Q1 '26: 200.2M Q2 '26: 234.2M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-1.2B -800M -400M 0 400M 800M 1.2B Q3 '16: -82.2M Q4 '16: -81.7M Q1 '17: -120.9M Q2 '17: -143.4M Q3 '17: -142.5M Q4 '17: -116.9M Q1 '18: -107.6M Q2 '18: -112.7M Q3 '18: -254.8M Q4 '18: -282.4M Q1 '19: -298.5M Q2 '19: -236.8M Q3 '19: -41.8M Q4 '19: 21.5M Q1 '20: 84.1M Q2 '20: 97.1M Q3 '20: 110.8M Q4 '20: 106.2M Q1 '21: 142.8M Q2 '21: 508.9M Q3 '21: 530.3M Q4 '21: 528.4M Q1 '22: 527.3M Q2 '22: 173.1M Q3 '22: 167.6M Q4 '22: 175.1M Q1 '23: 182M Q2 '23: -917.3M Q3 '23: -952.3M Q4 '23: -1B Q1 '24: -1.1B Q2 '24: 9.2M Q3 '24: -2.5M Q4 '24: 880K Q1 '25: -32.3M Q2 '25: -7.9M Q3 '25: 28.5M Q4 '25: 24M Q1 '26: 102.2M Q2 '26: 129.9M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 15M 30M 45M Q4 '13: 7.2M Q1 '14: 7.9M Q2 '14: 15M Q3 '14: 4.1M Q4 '14: 5.3M Q1 '15: 3.4M Q2 '15: 1M Q3 '15: 1.8M Q4 '15: 12K Q4 '17: 19.1M Q1 '18: 21.2M Q2 '18: 21.7M Q3 '18: 20.3M Q4 '18: 32.8M Q1 '19: 31.2M Q2 '19: 38.4M Q3 '19: 34.3M Q4 '19: 23.9M Q1 '20: 25.1M Q2 '20: 13.8M Q3 '20: 13.3M Q4 '20: 3.1M Q4 '13 Q3 '14 Q2 '15 Q4 '17 Q3 '18 Q2 '19 Q1 '20 Q4 '20

Operating Cash Flow TTM

-200M -100M 0 100M 200M 300M Q3 '16: -26.1M Q4 '16: -25.9M Q1 '17: -53.9M Q2 '17: -80.1M Q3 '17: -110.7M Q4 '17: -100.8M Q1 '18: -103.8M Q2 '18: -94M Q3 '18: -89.4M Q4 '18: -70.9M Q1 '19: -82.4M Q2 '19: -68.9M Q3 '19: -7.6M Q4 '19: 10.7M Q1 '20: 96.7M Q2 '20: 126M Q3 '20: 144.9M Q4 '20: 168.8M Q1 '21: 198.9M Q2 '21: 227.4M Q3 '21: 248.8M Q4 '21: 261.9M Q1 '22: 252.3M Q2 '22: 265.1M Q3 '22: 259.1M Q4 '22: 273.8M Q1 '23: 289.8M Q2 '23: 263.4M Q3 '23: 226.8M Q4 '23: 183.4M Q1 '24: 148.2M Q2 '24: 146.7M Q3 '24: 124.2M Q4 '24: 103.5M Q1 '25: 78.5M Q2 '25: 30M Q3 '25: 67.7M Q4 '25: 127M Q1 '26: 112.2M Q2 '26: 185.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

-300M -200M -100M 0 100M 200M 300M Q3 '12: -69.1M Q4 '12: -83.6M Q1 '13: -132M Q2 '13: -168.6M Q3 '13: -263M Q4 '13: -282.9M Q1 '14: -246M Q2 '14: -200.9M Q3 '14: -181.1M Q4 '14: -159.1M Q1 '15: -137.7M Q2 '15: -127.2M Q3 '15: -114.6M Q4 '15: -111M Q1 '16: -74.1M Q2 '16: -54.5M Q3 '16: -29.9M Q4 '16: -30.1M Q1 '17: -58.2M Q2 '17: -84.5M Q3 '17: -115.1M Q4 '18: -71.2M Q1 '19: -84.5M Q2 '19: -69.3M Q3 '19: -12.4M Q4 '19: 3.5M Q1 '20: 91.3M Q2 '20: 118.5M Q3 '20: 140.4M Q4 '20: 167M Q3 '22: 258.9M Q4 '23: 183.2M Q1 '24: 147.9M Q2 '24: 146.4M Q3 '24: 123.8M Q4 '24: 103.4M Q1 '25: 78.4M Q2 '25: 29.9M Q3 '25: 67.6M Q4 '25: 127M Q3 '13 Q4 '14 Q1 '16 Q2 '17 Q3 '19 Q4 '20 Q3 '24 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q2 '10: 97.6M Q3 '10: 97.9M Q1 '11: 99.1M Q2 '11: 99.7M Q3 '11: 100.2M Q1 '12: 103.8M Q2 '12: 107.1M Q3 '12: 114.3M Q3 '13: 120.8M Q1 '19: 155K Q2 '19: 155.8K Q3 '19: 156.8K Q1 '20: 160M Q2 '20: 159.9M Q3 '20: 160.3M Q1 '21: 162.3M Q2 '21: 163.5M Q3 '21: 165.2M Q1 '22: 189.5M Q2 '22: 184.9M Q3 '22: 184.5M Q1 '23: 186.7M Q2 '23: 155.4M Q3 '23: 186.9M Q1 '24: 157.7M Q2 '24: 159M Q3 '24: 160.2M Q1 '25: 161M Q2 '25: 176.8M Q3 '25: 177.8M Q1 '26: 166.7M Q2 '26: 167.2M Q2 '11 Q3 '12 Q3 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-7.50 -5.00 -2.50 0.00 2.50 5.00 7.50 Q1 '15: -1.25 Q2 '15: -1.15 Q3 '15: -1.18 Q4 '15: -1.00 Q1 '16: -0.85 Q2 '16: -0.66 Q3 '16: -0.56 Q4 '16: -0.56 Q1 '17: -0.83 Q2 '17: -0.98 Q3 '17: -0.97 Q4 '17: -0.80 Q1 '18: -0.73 Q2 '18: -0.75 Q3 '18: -1.67 Q4 '18: -1.85 Q3 '20: 0.69 Q4 '20: 0.66 Q1 '21: 0.89 Q2 '21: 3.12 Q3 '21: 3.25 Q4 '21: 3.23 Q1 '22: 3.19 Q2 '22: 1.01 Q3 '22: 0.95 Q4 '22: 0.97 Q1 '23: 1.01 Q2 '23: -6.04 Q3 '23: -6.23 Q4 '23: -6.51 Q1 '24: -6.79 Q2 '24: 0.04 Q3 '24: -0.03 Q4 '24: -0.01 Q1 '25: -0.21 Q2 '25: -0.06 Q3 '25: 0.15 Q4 '25: 0.13 Q1 '26: 0.60 Q2 '26: 0.77 Q1 '16 Q2 '17 Q3 '18 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.